Literature DB >> 18470710

Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis, and septic shock.

F M Brunkhorst1, K Wegscheider, Z F Forycki, R Brunkhorst.   

Abstract

OBJECTIVE: To determine the value of procalcitonin (PCT) in the early diagnosis (and differentiation) of patients with SIRS, sepsis, severe sepsis, and septic shock in comparison to C-reactive protein (CRP), white blood cell and thrombocyte count, and APACHE-II score (AP-II).
DESIGN: Prospective cohort study including all consecutive patients admitted to the ICU with the suspected diagnosis of infection over a 7-month period. PATIENTS AND METHODS: A total of 185 patients were included: 17 patients with SIRS, 61 with sepsis, 68 with severe sepsis, and 39 patients with septic shock. CRP, cell counts, AP-II and PCT were evaluated on the first day after onset of inflammatory symptoms.
RESULTS: PCT values were highest in patients with septic shock (12.89+/-4.39 ng/ml;P<0.05 vs patients with severe sepsis). Patients with severe sepsis had significantly higher PCT levels than patients with sepsis or SIRS (6.91+/-3.87 ng/ml vs 0.53+/-2.9 ng/ml;P<0.001, and 0.41+/-3.04 ng/ml;P<0.001, respectively). AP-II scores did not differ significantly between sepsis, severe sepsis and SIRS (19.26+/-1.62, 16.09+/-2.06, and 17.42+/-1.72 points, respectively), but was significantly higher in patients with septic shock (29.27+/-1.35,P<0.001 vs patients with severe sepsis). Neither CRP, cell counts, nor the degree of fever showed significant differences between sepsis and severe sepsis, whereas white blood cell count and platelet count differed significantly between severe sepsis and septic shock.
CONCLUSIONS: In contrast to AP-II, PCT appears to be a useful early marker to discriminate between sepsis and severe sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 18470710     DOI: 10.1007/BF02900728

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  9 in total

Review 1.  American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.

Authors: 
Journal:  Crit Care Med       Date:  1992-06       Impact factor: 7.598

2.  Procalcitonin in early detection of postoperative complications.

Authors:  H B Reith; U Mittelkötter; E S Debus; C Küssner; A Thiede
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

3.  Early identification of biliary pancreatitis with procalcitonin.

Authors:  F M Brunkhorst; O K Eberhard; R Brunkhorst
Journal:  Am J Gastroenterol       Date:  1998-07       Impact factor: 10.864

Review 4.  Anti-inflammatory therapies to treat sepsis and septic shock: a reassessment.

Authors:  F Zeni; B Freeman; C Natanson
Journal:  Crit Care Med       Date:  1997-07       Impact factor: 7.598

5.  Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.

Authors:  F M Brunkhorst; O K Eberhard; R Brunkhorst
Journal:  Crit Care Med       Date:  1999-10       Impact factor: 7.598

6.  Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.

Authors:  O K Eberhard; M Haubitz; F M Brunkhorst; V Kliem; K M Koch; R Brunkhorst
Journal:  Arthritis Rheum       Date:  1997-07

7.  Sepsis, severe sepsis or sepsis syndrome: need for clarification.

Authors:  J L Vincent; D Bihari
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

8.  Procalcitonin in the early phase after renal transplantation--will it add to diagnostic accuracy?

Authors:  O K Eberhard; I Langefeld; E R Kuse; F M Brunkhorst; V Kliem; H J Schlitt; R Pichlmayr; K M Koch; R Brunkhorst
Journal:  Clin Transplant       Date:  1998-06       Impact factor: 2.863

9.  The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study.

Authors:  M S Rangel-Frausto; D Pittet; M Costigan; T Hwang; C S Davis; R P Wenzel
Journal:  JAMA       Date:  1995-01-11       Impact factor: 56.272

  9 in total
  69 in total

1.  Definition for septic syndrome should be re-evaluated.

Authors:  R Zahorec
Journal:  Intensive Care Med       Date:  2000-12       Impact factor: 17.440

2.  Microbial diagnostics in patients with presumed severe infection in the emergency department.

Authors:  S Hettwer; J Wilhelm; M Schürmann; H Ebelt; D Hammer; M Amoury; F Hofmann; A Oehme; D Wilhelms; A S Kekulé; T Klöss; K Werdan
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02       Impact factor: 0.840

3.  Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.

Authors:  Helena Brodská; Karin Malíčková; Václava Adámková; Hana Benáková; Markéta Marková Šťastná; Tomáš Zima
Journal:  Clin Exp Med       Date:  2012-05-27       Impact factor: 3.984

4.  Why we need a new definition of sepsis.

Authors:  Sarah J Beesley; Michael J Lanspa
Journal:  Ann Transl Med       Date:  2015-11

Review 5.  Urosepsis--Etiology, Diagnosis, and Treatment.

Authors:  Nici Markus Dreger; Stephan Degener; Parviz Ahmad-Nejad; Gabriele Wöbker; Stephan Roth
Journal:  Dtsch Arztebl Int       Date:  2015-12-04       Impact factor: 5.594

Review 6.  [Sepsis. Update on pathophysiology, diagnostics and therapy].

Authors:  M Bauer; F Brunkhorst; T Welte; H Gerlach; K Reinhart
Journal:  Anaesthesist       Date:  2006-08       Impact factor: 1.041

Review 7.  Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection.

Authors:  Saif Ahmad; Anjali Tejuja; Kimberley D Newman; Ryan Zarychanski; Andrew Je Seely
Journal:  Crit Care       Date:  2009-11-24       Impact factor: 9.097

8.  Evaluation of recovery in iatrogenic evoked acute mediatinitis.

Authors:  Sławomir Jabłoński; Marcin Kozakiewicz
Journal:  Inflammation       Date:  2013-10       Impact factor: 4.092

Review 9.  [Diagnosis and therapy of sepsis. Guidelines of the German Sepsis Society Inc. and the German Interdisciplinary Society for Intensive and Emergency Medicine].

Authors:  K Reinhart; F Brunkhorst; H Bone; H Gerlach; M Gründling; G Kreymann; P Kujath; G Marggraf; K Mayer; A Meier-Hellmann; C Peckelsen; C Putensen; M Quintel; M Ragaller; R Rossaint; F Stüber; N Weiler; T Welte; K Werdan
Journal:  Internist (Berl)       Date:  2006-04       Impact factor: 0.743

10.  Prevention, diagnosis, therapy and follow-up care of sepsis: 1st revision of S-2k guidelines of the German Sepsis Society (Deutsche Sepsis-Gesellschaft e.V. (DSG)) and the German Interdisciplinary Association of Intensive Care and Emergency Medicine (Deutsche Interdisziplinäre Vereinigung für Intensiv- und Notfallmedizin (DIVI)).

Authors:  K Reinhart; F M Brunkhorst; H-G Bone; J Bardutzky; C-E Dempfle; H Forst; P Gastmeier; H Gerlach; M Gründling; S John; W Kern; G Kreymann; W Krüger; P Kujath; G Marggraf; J Martin; K Mayer; A Meier-Hellmann; M Oppert; C Putensen; M Quintel; M Ragaller; R Rossaint; H Seifert; C Spies; F Stüber; N Weiler; A Weimann; K Werdan; T Welte
Journal:  Ger Med Sci       Date:  2010-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.